Life Sciences: represents and advises life sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early - stage life science and
emerging life sciences companies.
Not exact matches
It invests in
companies with a global vision, keeping the focus on perceived
emerging sectors: technology, digital industries, technologies for industry and
life sciences.
Rob Tyler has dedicated the past 17 years to helping entrepreneurs grow
emerging technology
companies in a variety of industries, including information technology,
life sciences, medical devices, healthcare, nanotechnology, and advanced materials.
Our
Emerging Growth and Venture Capital practice group assists start - ups and emerging companies in various fields, including information technology, telecommunications, life sciences and clean
Emerging Growth and Venture Capital practice group assists start - ups and
emerging companies in various fields, including information technology, telecommunications, life sciences and clean
emerging companies in various fields, including information technology, telecommunications,
life sciences and clean - tech.
Founded in 1981, Zero Stage Capital is a venture capital firm that invests in
emerging growth
companies in the following technology sectors: information technology, communications,
life sciences, and energy technology.
TechAlliance focuses on networking, knowledge - sharing, capitalization, and member marketing initiatives for over 125 regional IT,
life sciences and advanced manufacturing
companies as well as related professional service providers, and is committed to helping develop the region's
emerging knowledge - based industries into a collective economic powerhouse.
10.30 - 11.00 Stackebradt, Erko (Professor, Leibnitz Institute, DSMZ - German Collection of Microorganisms and Cell Cultures; Coordinator, MIRRI - Microbial Resource Research Infrastructure, Braunschweig, Germany): Scientists and (their) microbial resources: responsibilities revisited 11.00 - 11.30 Balázs, Ervin (Member of HAS, Professor, Director - general, Centre for Agricultural Reserch, Hungarian Academy of
Science, Martonvárár, Hungary): Microbes serving agri - food industry 11.30 - 12.00 Coffee break 12.00 - 12.30 Nagy, Károly (Professor, Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary): How science supports management of emerging infections 12.30 - 13.00 Rajnavölgyi, Éva (Professor, Department of Immunology, University of Debrecen, Debrecen, Hungary): Human life in invisible company - The significance of preventive vacc
Science, Martonvárár, Hungary): Microbes serving agri - food industry 11.30 - 12.00 Coffee break 12.00 - 12.30 Nagy, Károly (Professor, Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary): How
science supports management of emerging infections 12.30 - 13.00 Rajnavölgyi, Éva (Professor, Department of Immunology, University of Debrecen, Debrecen, Hungary): Human life in invisible company - The significance of preventive vacc
science supports management of
emerging infections 12.30 - 13.00 Rajnavölgyi, Éva (Professor, Department of Immunology, University of Debrecen, Debrecen, Hungary): Human
life in invisible
company - The significance of preventive vaccination
The center focuses «on promoting a thriving
science and technology sector in Maine by facilitating innovation - and entrepreneurial - based learning and by nurturing
emerging life science and technology
companies,» the lab's website says.
The new center will promote a thriving
science and technology sector in Maine by facilitating innovation - and entrepreneurial - based learning and by nurturing
emerging life science and technology
companies.
SVB Financial Group engages in the provision of diversified financial services to
emerging, growth and established technology
companies and the
life science, cleantech, venture capital, private equity and premium wine markets.
Supporting these fast - growing
companies to ensure that they continue to scale — and eventually exit — here should be a strategic priority, particularly at a time when a new generation of fast - growth providers, such as Prowler.io and Benevolent AI in
life sciences, and ThoughtRiver in legal tech, is
emerging to build on an impressive track record of AI innovation in the UK, from Alan Turing to DeepMind.
«He has a unique strength in counseling
emerging growth
companies, including in the
life sciences industry, which is an expanding practice for the firm.»
The four corporate attorneys all focus on
emerging companies in the technology, clean technology, and
life sciences industries.
«These dedicated individuals are representative of our firm's core strengths in
life sciences, venture capital and
emerging companies, private equity, technology, M&A and healthcare,» said Foley Hoag co-managing partner Jeffrey Collins.
«The addition of Robert Chow to our
Emerging Companies and Venture Capital practice group will benefit many of our clients, especially those in the technology, healthcare and
life sciences areas,» said Foley Hoag Co-Managing Partner Kenneth Leonetti.
For
life sciences companies in every stage of development, the
emerging business and technology team at Morgan Lewis provides customized legal guidance and international connection to address critical business issues.Our lawyers and technical specialists in North America, Asia, Europe, and the Middle East deliver pragmatic, goal - oriented advice for
life sciences companies.
McDermott created the innovative
Life Sciences Entrepreneurs Acceleration Program (LEAP) in 2013 to help emerging and early - stage life sciences companies grow by offering affordable access to strategic legal advice on the full range of transactional, intellectual property, and employment matte
Life Sciences Entrepreneurs Acceleration Program (LEAP) in 2013 to help
emerging and early - stage
life sciences companies grow by offering affordable access to strategic legal advice on the full range of transactional, intellectual property, and employment matte
life sciences companies grow by offering affordable access to strategic legal advice on the full range of transactional, intellectual property, and employment matters..
The Ontario
Emerging Technologies Fund — which has met with some criticism for the onerous disclosure required to qualify as an investor and for restrictions on investees» deployment of invested funds — showed this week that it can nevertheless fund
life science companies and qualify biotech investors.
Our corporate attorneys represent clients in the biotechnology and
life sciences industry regardless of whether those clients are not - for - profit entities,
emerging companies or multi-million dollar private or public
companies.
Advantage: Access to current &
emerging careers, organization changes &
company news in the pharmaceutical, biopharma &
life sciences industries.
Mary C. Casey, Esq., is the founder of the Harbor Law Group, a law firm specializing in corporate and intellectual property law and providing counsel to start - ups and
emerging companies in the
life sciences, biotech and high technology fields.